Perioperative Risk Factors for Postoperative Pulmonary Complications After Minimally Invasive Esophagectomy
Xiaoxi Li,Ling Yu,Miao Fu,Jiaonan Yang,Hongyu Tan
DOI: https://doi.org/10.2147/ijgm.s449530
IF: 2.145
2024-02-16
International Journal of General Medicine
Abstract:Xiaoxi Li, Ling Yu, Miao Fu, Jiaonan Yang, Hongyu Tan Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Anesthesiology, Peking University Cancer Hospital & Institute, Beijing, China Correspondence: Hongyu Tan, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Anesthesiology, Peking University Cancer Hospital & Institute, &num52 Fucheng Street, Haidian District, Beijing, 100142, China, Tel/Fax +8610-88196107, Email Background: Postoperative pulmonary complications (PPCs) are the most prevalent complication after esophagectomy and are associated with a worse prognosis. This study aimed to investigate the perioperative risk factors for PPCs after minimally invasive esophagectomy (MIE). Methods: Seven hundred and sixty-seven consecutive patients who underwent McKeown MIE via thoracoscopy and laparoscopy were retrospectively studied. Patient characteristics, perioperative data, and postoperative complications were analyzed. Results: The incidence of PPCs after MIE was 25.2% (193/767). Univariate analysis identified age (odds ratio [OR] 1.022, P = 0.044), male sex (OR 2.955, P < 0.001), pulmonary comorbidities (OR 1.746, P = 0.032), chronic obstructive pulmonary disease (COPD) (OR 2.821, P = 0.003), former smoking status (OR 1.880, P = 0.001), postoperative albumin concentration (OR 0.941, P = 0.007), postoperative creatinine concentration (OR 1.011, P = 0.019), and perioperative transfusion (OR 2.250, P = 0.001) as risk factors for PPCs. In multivariate analysis, the independent risk factors for PPCs were male sex (OR 3.135, P < 0.001), body mass index (BMI) (OR 1.088, P = 0.002), COPD (OR 2.480, P = 0.012), neoadjuvant chemoradiotherapy (OR 2.057, P = 0.035), postoperative albumin concentration (OR 0.929, P = 0.002), and perioperative transfusion (OR 1.939, P = 0.013). The area under the receiver operating characteristic curve for the predictive model generated by multivariate logistic regression analysis was 0.671 (95% confidence interval 0.628– 0.713). Conclusions: Male sex, BMI, COPD, neoadjuvant chemoradiotherapy, postoperative albumin concentration, and perioperative transfusion were independent predictors of PPCs after MIE. Keywords: esophageal cancer, minimally invasive esophagectomy, postoperative pulmonary complications, perioperative risk factors, predictive model Esophagectomy is associated with high risks of mortality and morbidity, particularly postoperative pulmonary complications (PPCs), 1 which are strongly associated with increased durations of ventilation, intensive care, and hospitalization, and are reported to adversely affect overall survival. 2–5 Recently, minimally invasive esophagectomy (MIE) has become a standard procedure for the surgical treatment of esophageal cancer. MIE is reportedly associated with significantly better short-term outcomes than open esophagectomy. 6,7 Studies have also found a lower incidence of PPCs in patients undergoing MIE compared with open surgery. 8–10 In a multi-center randomized controlled trial of patients undergoing esophagectomy, the incidence of a major pulmonary complication was 18% in the hybrid-procedure group and 30% in the open-procedure group. 9 Additionally, MIE reportedly decreases the risk of respiratory failure after esophagectomy. 11 However, PPCs remain a major concern after MIE, and the risk factors related to PPCs after MIE have not been fully investigated. Therefore, it would be beneficial for both patients and healthcare providers to identify the perioperative risk factors that influence the development of PPCs, especially regarding the best protective strategies during perioperative management of MIE to enhance clinical decision-making. The aim of this study was to assess the perioperative risk factors that influence the occurrence of PPCs after total MIE. This study was approved by the Ethics Committee of Peking University Cancer Hospital, Beijing, China. The need for patient consent was waived by the ethics committee due to the retrospective study design. The data analyzed in the study were anonymized and the study was conducted in accordance with the Declaration of Helsinki. The study was registered in the Chinese Clinical Trial Registry (No. ChiCTR2300071822). Consecutive patients who were diagnosed with esophageal cancer and underwent McKeown MIE via thoracoscopy and laparoscopy between January 2016 and February 2023 were retrospectively studied. Patients with cervical esophageal cancer, esophageal cancer recurrence, an American Society of Anesthesiologists grade of greater than class III, a diagnosis of COVID-19 within 1 month prior to surgery or during h -Abstract Truncated-
medicine, general & internal